DIVIS LABORATORIES
Back to Cashflow Statement
|
DIVIS LABORATORIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-799 Cr | ₹-799 Cr | ₹-797 Cr | ₹-532 Cr | ₹-35 Cr |
What is the latest Cash Flow from Financing Activities ratio of DIVIS LABORATORIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-799 Cr |
| Mar2024 | ₹-799 Cr |
| Mar2023 | ₹-797 Cr |
| Mar2022 | ₹-532 Cr |
| Mar2021 | ₹-35 Cr |
How is Cash Flow from Financing Activities of DIVIS LABORATORIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-799 Cr | Negative | |
| Mar2024 | ₹-799 Cr | Negative | |
| Mar2023 | ₹-797 Cr | Negative | |
| Mar2022 | ₹-532 Cr | Negative | |
| Mar2021 | ₹-35 Cr | - | |
Compare Cash Flow from Financing Activities of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹179,758.1 Cr | 3.5% | 2.2% | 0.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,593.0 Cr | 2% | 6.7% | 14.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹164,290.0 Cr | 4.6% | 9.9% | 41.5% | Stock Analytics | |
| CIPLA | ₹117,327.0 Cr | -0.3% | 3.7% | -2.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,994.0 Cr | 1.1% | 5.9% | 6.6% | Stock Analytics | |
| MANKIND PHARMA | ₹104,550.0 Cr | 1.7% | 8.3% | 9.4% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 3.5% |
2.2% |
0.6% |
| SENSEX | 2.2% |
5.1% |
-7% |
You may also like the below Video Courses